Suven Life Sciences Ltd

NSE: SUVEN · BSE: 530239 · Healthcare · 30 announcements

Share price: ₹305.55
Market cap: ₹8,634 Cr
Revenue (annual): ₹7.11 Cr
Net profit (annual): ₹-276.3 Cr
P/E (TTM): -24.5×Sector 53.1×
Promoter holding: 65.47%-4.68% QoQ
FII holding: 0.48%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

8 Jul 2026 12:51 IST NSE

Suven Life Sciences Fund Raise of ₹248.8 Cr

Suven Life Sciences raised ₹248.84 Crore via preferential allotment of 1.85 Crore equity shares at ₹134 each. Paid‑up capital now stands at 282.56 Million shares.

Value: ₹248.8 Cr

Read the filing ↗

14 May 2026 12:43 IST BSE

Fund Raise

Suven Life Sciences Fund Raise of ₹857.6 Cr

Suven Life Sciences Limited released its quarterly Monitoring Agency Report for the ₹857.64 Crore preferential issue. CRISIL confirmed fund utilization aligns with stated objects for March 2026.

Value: ₹857.6 Cr

Read the filing ↗